SANDER A FLAUM

CIK 1261026 · last filed 2019-03-06

SANDER A FLAUM is a corporate insider who has filed 14 SEC Form 4 insider transactions across 2 companies since 2007. The most recent filing, for EGRX, was dated Mar 6, 2019. Across all open-market trades the lifetime net is −$1.2M, making them a net seller over the disclosed history.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

2

Total Filings

14

Lifetime Open-Market Net

-$1.23M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted Director 13,714 $2.14 $29.3K -$1.23M 11 2019-03-06
VIASYS HEALTHCARE INC (VAS) Delisted Director 17,000 $0 2 2007-06-25

Recent Filings

14 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2019-03-06 EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted Mixed +2,136 -$520 EDGAR
2019-01-25 EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted Grant (A) $0 EDGAR
2018-03-07 EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted Mixed -$124.1K EDGAR
2018-01-09 EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted Grant (A) $0 EDGAR
2017-01-06 EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted Grant (A) $0 EDGAR
2016-11-30 EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted Sell (S) −5,000 -$393.3K EDGAR
2016-01-05 EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted Grant (A) $0 EDGAR
2015-12-23 EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted Sell (S) −13,025 -$714.0K EDGAR
2015-04-22 EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted Grant (A) $0 EDGAR
2015-03-17 EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted Grant (A) $0 EDGAR
Showing 110 of 14
Page 1 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.